KEY FEATURES
| Full Name | Poly ADP Ribose Polymerase |
|---|---|
| Synonym | PARP1; ADPRT; ADPRT1; PPOL; pADPRT-1; ADP-ribosyltransferase diphtheria toxin-like 1; NAD(+) ADP-ribosyltransferase 1 |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse PARP in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse PARP. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse PARP and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse PARP, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse PARP. You can calculate the concentration of Mouse PARP in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse PARP ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.98 | 1.85 | 9.88 | 0.92 | 1.79 | 9.37 |
| Standard deviation | 0.06 | 0.08 | 0.44 | 0.05 | 0.09 | 0.51 |
| CV(%) | 5.83 | 4.44 | 4.5 | 5.8 | 5.26 | 5.42 |
RECOVERY
The recovery of Mouse PARP spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 86-99 | 92 |
| EDTA plasma (n=8) | 93-106 | 99 |
| Cell culture media (n=8) | 83-99 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse PARP in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CASP3 ELISA Kits
| CASP9 ELISA Kit | publications with CASP3 and CASP9 |
| CASP8 ELISA Kit | publications with CASP3 and CASP8 |
| XIAP ELISA Kit | publications with CASP3 and XIAP |
| AKT1 ELISA Kit | publications with CASP3 and AKT1 |
| APAF1 ELISA Kit | publications with CASP3 and APAF1 |
| PARP1 ELISA Kit | publications with CASP3 and PARP1 |
| CASP10 ELISA Kit | publications with CASP3 and CASP10 |
| BIRC3 ELISA Kit | publications with CASP3 and BIRC3 |
| BIRC2 ELISA Kit | publications with CASP3 and BIRC2 |
| BCL2L11 ELISA Kit | publications with CASP3 and BCL2L11 |
Pathways associated with CASP3 ELISA Kit
| AGE/RAGE Pathway | AGE/RAGE Pathway |
| Activation Of DNA Fragmentation Factor Pathway | Activation Of DNA Fragmentation Factor Pathway |
| Activation Of Caspases Through Apoptosome-mediated Cleavage Pathway | Activation Of Caspases Through Apoptosome-mediated Cleavage Pathway |
| Alpha6-Beta4 Integrin Signaling Pathway | Alpha6-Beta4 Integrin Signaling Pathway |
| Alzheimer's Disease Pathway | Alzheimer's Disease Pathway |
| Alzheimers Disease Pathway | Alzheimers Disease Pathway |
| Amoebiasis Pathway | Amoebiasis Pathway |
| Amyotrophic Lateral Sclerosis (ALS) Pathway | Amyotrophic Lateral Sclerosis (ALS) Pathway |
Diseases associated with CASP3 ELISA Kit
| Neoplasms | publications with CASP3 and Neoplasms |
| Necrosis | publications with CASP3 and Necrosis |
| Drug Toxicity | publications with CASP3 and Drug Toxicity |
| Nervous System Diseases | publications with CASP3 and Nervous System Diseases |
| Inflammation | publications with CASP3 and Inflammation |
| Liver Diseases | publications with CASP3 and Liver Diseases |
| Brain Ischemia | publications with CASP3 and Brain Ischemia |
| Heart Diseases | publications with CASP3 and Heart Diseases |
| Breast Neoplasms | publications with CASP3 and Breast Neoplasms |
| Nerve Degeneration | publications with CASP3 and Nerve Degeneration |
Organs/Tissues associated with CASP3 ELISA Kit
| Blood | publications with CASP3 and Blood |
| Brain | publications with CASP3 and Brain |
| Liver | publications with CASP3 and Liver |
| Muscle | publications with CASP3 and Muscle |
| Vascular | publications with CASP3 and Vascular |
| Lung | publications with CASP3 and Lung |
| Heart | publications with CASP3 and Heart |
| Kidney | publications with CASP3 and Kidney |
| Bone | publications with CASP3 and Bone |
| Prostate | publications with CASP3 and Prostate |